ImThera gets EU approval for sleep apnea device trial

10/5/2009 | San Diego Business Journal

ImThera Medical received approval from the EU to conduct in early 2010 a 12-patient study of a device designed to treat obstructive sleep apnea. Called aura6000, the system uses implantable electrodes that electrically stimulate tongue muscles to keep the tongue from blocking the upper airway.

View Full Article in:

San Diego Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN